TuHURA Biosciences receives U.S. patent for delta opioid receptor antibody drug conjugate technology
HURA•TuHURA Biosciences received a U.S. patent for its delta opioid receptor antibody drug conjugate technology.
1. Patent received
TuHURA Biosciences said it received a U.S. patent for its delta opioid receptor antibody drug conjugate technology.
